Followers | 48 |
Posts | 1181 |
Boards Moderated | 0 |
Alias Born | 04/20/2018 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, March 16, 2019 2:34:59 PM
When I ask CELZ leadership to help provide some clarity on their own issued 8k's from 3-10 months ago, I would expect they would want to clarify with shareholders. That's normal business.
1. Where are Freedman/Wachs? Why do you announce they are CaverStem doctors in 2018 and put them on the old website but in 2019 I can't find them in 2019.
2. Why can't a shareholder locate anything on Gary Mells who CMTH/CELZ leadership put in an 8k in 2018 as the companies newly higher sales executive, yet he can't be found on LinkedIn. Every sales exec for a Fortune 500 company who is employed is on LinkedIn. Warbington, Dickerson, myself and all other sales/bus execs are on LinkedIn but Gary Mells is absent. Where is he? Who is he? Doesn't add up.
3. Why did CMTH/CELZ leadership last summer announce via 8k a contract with PromoMed Russia and that AltoUro and Switzerland had joined CaverStem with contracts, yet 6 months later, we know nothing.
Those are just a few items which CMTH/CELZ who doesn't put out PR's/8k's often announced a substantial time ago, but will not address when asked multiple times by myself over the past 5 months.
I have 6.5M shares and $110k invested and have held for 9+ months. I don't expect CMTH/CELZ to do anything special for me; however, as a shareholder, the questions I raise above are items CMTH/CELZ leadership put forward as accomplishments to investors, yet have not followed up regarding.
There is a lack of trust. The sooner we all group together and request a shareholder call or written clarification to some questions, the sooner trust is built and our SP is where it should be, above $.05 permanently!
Enjoy the weekend all.
CF
Recent CELZ News
- Creative Medical Technology Holdings Announces Evolutionary Development of its iPSCelz® Program with the Successful Generation of iPSC Derived Islet Cells that Produce Human Insulin • GlobeNewswire Inc. • 06/24/2024 12:30:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/05/2024 08:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:02:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:45:39 PM
- Creative Medical Technology Holdings Provides Corporate Update • Business Wire • 03/27/2024 01:00:00 PM
- Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access • Business Wire • 03/07/2024 02:15:00 PM
- Biotech Finds Mid-Week Success Following FDA Announcement • AllPennyStocks.com • 03/06/2024 09:10:00 PM
- Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy • Business Wire • 03/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 09:05:37 PM
- Creative Medical Technology Holdings Provides Corporate Update • PR Newswire (US) • 11/15/2023 01:00:00 PM
- Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain • PR Newswire (US) • 10/10/2023 12:00:00 PM
- Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain • PR Newswire (US) • 09/19/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 08:45:38 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM